WASHINGTON -- Staying out of trouble with FDA in clinical research requires sponsors to undergo a careful R&D compliance assessment. Areas that should be closely scrutinized include leadership and accountability, training, policies, communication and reportin...

Current hepatitis C treatment has many drawbacks, including significant side effects, high cost, and the need for injections of pegylated interferon IFN Any of a group of glycoproteins that are produced by different cell types in response to various stimuli, such as...

The U.S. District Court for the District of Maryland has granted a motion by Roche Diagnostics diagnostics /di·ag·nos·tics/ (di?ag-nos´tiks) the science and practice of diagnosis of disease. GmbH to compel IGEN to produce documents pertaining to IGEN's ...

Tokyo, Japan, Dec 26, 2006 - (JCN) - Shionogi announced on December 22 that it has achieved the primary objectives of Phase III clinical trials for the idiopathic 1. Of or relating to a disease having no known cause; agnogenic.2. Of or relating to a disease that is...

SOUTH SAN FRANCISCO and SAN DIEGO, Calif.--(BUSINESS WIRE)-- March 16, 1995--Genentech, Inc. (NYSE:GNE) and IDEC IDEC - Information Design & End-User ComputingIDEC - Instituto Brasileiro de Defesa do Consumidor (Portugese: Brazilian Consumer Protection Agency)IDEC - I...

Cerus Corporation (Nasdaq:CERS CERS - Carrier Evaluation & Reporting SystemCERS - Cerus Corporation (stock symbol)CERS - Class Event and Resource Scheduler (STASS)CERS - Collection/Exam Referral SystemCERS - Combat Environment Realism SystemCERS - Commander Emergency...

Shares of InterMune, Inc. have more than doubled in price since early April, which is roughly the rate at which revenues are expected to grow for ActImmune, a treatment for chronic granulomatous disease and severe malignant osteoporosis. For the second consecutive qua...

Clinical Question: Does interferon gamma-1b (Actimmune) reduce mortality in patients with idiopathic pulmonary fibrosis? ...

Health/Medical Writers ...

InterMune (Nasdaq: ITMN), Burlingame, Calif. and Boehringer Ingelheim International GmbH, Germany, have formed an international strategic partnership to develop and commercialize interferon gamma-1b under Boehringer Ingelheim's trade name, Imukin(R), in all countries ...

Business Editors/Legal Writers/Health/Medical Writers ...

Eight leading analysts and top management from eighty-two sector firms examine the Healthcare sector in this special 288-page UBS Warburg Global Life Sciences Conference 2000 issue from The Wall Street Transcript (212/952-7433) or www.twst.com/info/info181.htm ...